Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
The discontinuation of anti-VEGF treatment is common among individuals with neovascular AMD. Causes of discontinuation include not only clinician decisions but also those related to the patient's health and personal choices.
Authors
- Enrico Borrelli (ORCID: https://orcid.org/0000-0003-2815-5031)
- Ugo Introini (ORCID: https://orcid.org/0000-0001-9372-6107)
- Francesco Bandello (ORCID: https://orcid.org/0000-0003-3238-9682)
- Maria Oliva Grassi (ORCID: https://orcid.org/0000-0002-5952-7910)
- Paola Marolo (ORCID: https://orcid.org/0000-0002-8881-0926)
- Annamaria Porreca (ORCID: https://orcid.org/0000-0003-3278-1561)
- Michele Reibaldi (ORCID: https://orcid.org/0000-0003-1368-6729)
- Giacomo Boscia (ORCID: https://orcid.org/0000-0002-8768-899X)
- Pasquale Viggiano (ORCID: https://orcid.org/0000-0002-0323-967X)
- Francesco Boscia (ORCID: https://orcid.org/0000-0002-5478-060X)
- Carla Di Gennaro
- Rebecca Toscani (ORCID: https://orcid.org/0009-0003-9887-8080)
- Lorena Ulla
- Claudio Foti (ORCID: https://orcid.org/0009-0003-0412-4107)
- Alba Chiara Termite
- Mario Peronetti
Institutions
- Vita-Salute San Raffaele University (IT)
- CTO Hospital (IT)
- Piedmont Reference Center for Epidemiology and Cancer Prevention (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Turin (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- British Journal of Ophthalmology
- Published
- 2025-03-23
- DOI
- https://doi.org/10.1136/bjo-2024-326152
- Citations
- 6
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 10.24